A new approach to the treatment of atherosclerosis and trapidil as an antagonist to platelet-derived growth factor.
D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy* / Q000209:etiology; D001792:Blood Platelets / Q000502:physiology*; D002455:Cell Division / Q000187:drug effects; D002472:Cell Transformation, Viral; D002478:Cells, Cultured; D004261:DNA Replication / Q000187:drug effects; D006133:Growth Substances / Q000494:pharmacology* / Q000502:physiology; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D010455:Peptides / Q000494:pharmacology* / Q000502:physiology; D010982:Platelet-Derived Growth Factor; D011743:Pyrimidines / Q000494:pharmacology*; D013539:Simian virus 40; D014192:Trapidil / Q000494:pharmacology* / Q000627:therapeutic use
D006133:Growth Substances; D010455:Peptides; D010982:Platelet-Derived Growth Factor; D011743:Pyrimidines; D014192:Trapidil